EBC-170058
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
138926-19-9
Purity
95%
Ibandronate sodium hydrate is a bisphosphonate. It is used to prevent and treat postmenopausal osteoporosis. Ibandronate sodium hydrate induces apoptosis of hematopoietic tumor cells by inhibiting the components of the mevalonate pathway farnesyl pyrophosphate synthase.
Properties
Name
Ibandronate sodium hydrate
Smiles
O.[Na+].CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-]
Targets
Please log in to see this information
Impurity
SDS
Ibandronate sodium | ibandronate sodium hydrate | ibandronate sodium monohydrate | sodium ibandronate monohydrate
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
Ibandronate sodium | ibandronate sodium hydrate | ibandronate sodium monohydrate | sodium ibandronate monohydrate
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:114084-78-5
0